1 / 28

EC365 Theory of Monopoly and Regulation Topic 4: Merger

EC365 Theory of Monopoly and Regulation Topic 4: Merger. 2013-14, Spring Term Dr Helen Weeds. Routes to monopoly power. Monopoly power. Collude. Exclude. Merge. What is a merger?. Legal control: > 50% of voting shares Material influence: ability to influence policy

idola-carr
Download Presentation

EC365 Theory of Monopoly and Regulation Topic 4: Merger

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. EC365 Theory of Monopoly and RegulationTopic 4: Merger 2013-14, Spring Term Dr Helen Weeds

  2. Routes to monopoly power Monopoly power Collude Exclude Merge

  3. What is a merger? • Legal control: > 50% of voting shares • Material influence: ability to influence policy • 25% shareholding (can block special resolutions) • > 15% may attract scrutiny • BSkyB/ITV: BSkyB acquired 17.9% stake in ITV • Newscorp/BSkyB: held 39% already, wanted to increase to 100% • other factors: distribution of remaining shares; voting restrictions; board representation; specific agreements • Includes joint ventures (JVs) • combine operations in one area only • autonomous entity, e.g. jointly-owned subsidiary

  4. Motives for merger • Horizontal merger • Market power • towards customers • towards suppliers (monopsony) • Efficiencies and synergies • cost savings • R&D spillovers • Vertical merger (lecture 6): complementary assets • Conglomerate mergers: portfolio effects • Stock market: under-pricing; corporate control

  5. Lecture outline • Measuring concentration • Merger in Cournot oligopoly • symmetric firms • asymmetric firms • cost efficiencies • merger policy and case: Staples-Office Depot • R&D joint ventures • Relevant counterfactual • “failing firm defence”

  6. Measuring concentration • Symmetric firms • Market share of each firm, s = 1/n, may be used • E.g. 3 firms: s = 1/3 • Asymmetric firms: no unique measure • (r firm) Concentration Ratio: CRr = • Herfindahl-Hirschman index: HHI or H = • Monopoly: CR = HHI = 1 (as %: HHI = 10,000) • Perfect competition: both approx. 0

  7. Example: UK supermarkets • Market shares by retail by revenue • (2002/03) sales area excl. petrol • Tesco 26% 31% • Sainsbury’s 23% 21% • Asda (Wal-Mart) 19% 21% • Safeway 15%13% • Morrisons 7% 7% • [Others 9% 6%] • C4 ratio? HHI? • Market: one-stop grocery shopping (stores over 1,400 sq m); local (these are national shares)

  8. Use of HHI in merger control • US DoJ “safe harbours”; OFT guidelines

  9. Merger in Cournot oligopoly • Simple symmetric case • identical marginal cost c; no fixed costs • linear demand: P = a – bQ • Cournot with n firms • set a = b = 1; c = 0

  10. General case • n symmetric firms; 2 merge • Gain to merged firm:  = i(n–1) – 2i(n) • sgn  = sgn[2–(n–1)2]: negative when n > 1+2  2.4 • Competitors benefit from positive externality • merged firm q • competitors q (RFs slope down) • while P

  11. Why merge? • Cost asymmetries • merger reallocates output to more efficient plant • Efficiencies / synergies resulting from merger • fixed cost savings • marginal cost reductions • complementary assets • R&D • Post-merger collusion • assess change in critical discount factor 

  12. Cost asymmetries • Pre-merger • 2 firms, unit costs c1 = 1, c2 = 4; demand p = 10 –Q • Cournot eqm: • q1 = 4, q2 = 1; p = 5 • welfare: W =  + CS = 16 + 1 + 12.5 = 29.5 • Post-merger: shut down unit 2 • monopoly with c = 1: p = 5.5, Q = 4.5 • welfare: W =  + CS = 20.25 + 10.125 = 30.375 • Despite concentration, welfare goes up • what if W =  + CS, with  = 0.5? Critical ?

  13. Concentration and average margin • n-firm Cournot oligopoly • asymmetric marginal costs, ci • lower ci higher equilibrium qi  higher market share si • Relationship between HHI (as fraction, i.e.  1) and weighted average PCM (“Lerner index”) where  = price elasticity of demand (as absolute value)

  14. Cost reductions • What if merger reduces costs? • Fixed cost saving • lower F implies  • higher concentration implies P and CS • Marginal cost reduction • effect on P (and CS) is ambiguous • higher concentration • output where MR = MC is altered • NB: Cost savings must be merger-specific

  15. Fixed cost saving • Merger to monopoly • (inverse) demand P = 1–Q; marginal cost c = 0 • per-firm fixed cost F (0, 1/9) • Pre-merger (Cournot) • welfare W(n=2) =  + CS =2(1/9 –F) + 2/9 = 4/9 – 2F • Post-merger: eliminate one F • welfare W(n=1) =  + CS =¼ –F + 1/8 = 3/8 –F • Welfare comparison • welfare increases iff F > 5/72  0.07 • what if  < 1?

  16. Marginal cost reduction • Merger to monopoly • P = a – bQ; marginal cost falls from c0 to c1 < c0 • look at CS alone ( = 0) • Pre-merger (Cournot): • Post-merger: • CS increases iff • 

  17. Figure 1: Marginal cost reduction

  18. Merger policy • US: Clayton Act (1914) • “substantial lessening of competition” (SLC) test • UK: Enterprise Act (2002) • replaced “public interest” criteria with SLC test • EU merger regulation (1989/2003) • 1989: “create or enhance a dominant position” • 2003: “significant impediment to effective competition”, including creation or strengthening of a dominant position • captures reduction of competition in an oligopoly industry (without losing existing case law)

  19. Assessing a merger (OFT guidance 2003) • Competitive assessment • loss of rivalry, not constrained by other competitors? • entry: sufficient in scope, likely and timely? • buyer power: will this constrain any price rise? • Are there offsetting efficiency gains, benefiting consumers? • Relevant counterfactual • what would happen absent the merger? • e.g. is the target a “failing firm”?

  20. Competitive assessment • Are merging firms (close) competitors? • bidding data • diversion ratio: if A raises price, what proportion of lost demand goes to B? (ratio of cross- to own-price elasticity) • Other competitors • does presence of third parties constrain prices? • supply side as well as demand substitution • Framework: “market definition” • set of products which compete closely with one another • aspects: products, geographic market

  21. Case: Staples-Office Depot (US 1997) • Product: consumable office supplies • FTC’s market definition: “office superstores” (OSS) • Office Depot (1), Staples (2), OfficeMax (3) • merging parties had >70% share • non-OSS outlets: Wal-Mart, Kmart, Target, etc. • Issue: are non-OSS outlets in the same market? • econometric analysis of prices in local markets (cities) • prices lower where Staples competes with Office Depot than with non-OSS alone (FTC: 7.3%, parties: 2.4%) • prices lower where all 3 OSS compete than where Staples and OfficeMax alone • Competition effect: merger would raise prices

  22. Staples-Office Depot: cost savings • Would cost savings offset the (ve) competition effect? • Parties’ claims • large cost savings • 67% pass-through to customers • net effect:  prices by –2.2% • FTC’s claims • 43% of cost savings achievable without merger; some unreliable: actual savings = 1.4% of sales • 15% pass-through • net price effect = 7.3% – 0.15 x 1.4% = +7.1% • District Court ruled in favour of FTC: merger blocked

  23. R&D joint ventures • Innovation generates dynamic efficiency gains • Benefits of cooperative R&D • complementary skills/inputs of different firms • R&D involves large up-front costs; high risk • may be too much for one firm alone • Against cooperation • would each firm innovate on its own? • Likely to reduce R&D effort (Team issue) • more competitive product market is desirable

  24. Policy towards cooperative R&D • Principles underlying R&D JVs • research would not otherwise be undertaken • must not extend beyond activities necessary for R&D • e.g. joint R&D only; separate production & distribution • treated as a merger (rather than under Art. 101) if JV operates on an autonomous and permanent basis • some concern over networks of JVs involving same party: may inhibit competition / entry • E.g.: GM- Renault-Nissan JV to design a “light van” • Also joint production: large economies of scale • separate labels (Trafic, Vivaro), marketing and sales

  25. Counterfactual to the merger • Ideally, we want to compare • future with merger (1) • future without merger (2) • (2) often proxied by actual pre-merger situation • Sometimes using pre-merger is not valid • target will exit the market (it is a “failing firm”) • committed entry or expansion • regulatory changes: market liberalisation; new environmental controls

  26. Failing firm defence • Key idea • competition deteriorates even in the absence of merger • relative to this benchmark, merger does not lessen comp. • FFD: a merger which raises antitrust concerns may nonetheless be permitted if • the failing firm would otherwise exit • the acquirer would gain the target’s market share • no alternative purchaser poses a lesser threat to competition (regardless of price) [US; similar principles in EU, UK, etc.]

  27. Difficulties in using the FFD • Evidential difficulties • extent of losses?; are losses unavoidable? • e.g. Detroit newspapers: suspicion that firms were fighting “too hard” in order to gain merger clearance • are there other potential bidders? • Predictive difficulties • will losses continue?; will exit occur? • what would happen to market share, assets, etc? • Comparing 2 counterfactual situations • 2 hypotheticals not one

  28. Successful FFD cases • Potash: Kali und Salz–Mitteldeutsche Kali (EC 1993) • combined market share 98% • MdK very likely to go bankrupt (supported by Treuhand); 30% fall in demand 1988-93 • market share would go to K&S; no alternative purchaser • Solvents: BASF–Pantochim–Eurodiol (EC 2001) • targets already in receivership • no other buyer; merger would keep capacity in market • Other cases • Detroit News–Free Press: local newspapers (US 1988) • P&O–Stena: cross-Channel ferries (UK 1997) • Newscorp–Telepiù: Italian pay-TV (EC 2003)

More Related